Literature DB >> 17226101

Chemical validation of molecular mimicry: interaction of cholera toxin with Campylobacter lipooligosaccharides.

Seigo Usuki1, Mohanasundari Pajaniappan, Stuart A Thompson, Robert K Yu.   

Abstract

It is generally believed that molecular mimicry between bacterial lipooligosaccharide (LOS) and nerve glycolipids may play an important pathogenic role in immune-mediated peripheral neuropathy. One of the putative infectious agents is Campylobacter jejuni (C. jejuni). To elucidate the structural basis for the molecular mimicry, we investigated the structure of the lipooligosaccharide (LOS) fraction of C. jejuni, strain HS19, and found that it includes at least two components, characterized as fast-and slow-moving bands (LF and LS) by thin-layer chromatography as revealed by cholera toxin B subunit (Ctxb) overlay. Structural analysis of the oligosaccharide portion of LS established that it had the following structure: Gal-GalNAc-(NeuAc)Gal-Hep-(Glc;PO(3)H)Hep-Kdo. The GM1-like epitope was validated by a terminal tetrasaccharide unit within this structure. On the other hand, analysis of LF revealed an entirely different structure: 1, 4'-bisphosphoryl glucosamine disaccharide N, N'-acylated by 3-(2-hydroxytetracosanoyloxy)octadecanoic acid at 2- and 2'-positions, which is consistent with that of lipid A. No GM1-like epitope was observed in LF. Both LS and LF interacted with Ctxb as demonstrated by TLC-overlay and sucrose density gradient centrifugation. Surprisingly, LF does not have the basic GM1 structure for interacting with Ctxb. Instead, the affinity of LF to Ctxb required that one or both of the phosphate groups be present in the glucosamine disaccharide residue because after alkaline phosphatase treatment the dephosphorylated LF was unable to bind to Ctxb. We conclude that LS is likely the component contributing to GM1-mimicry in autoimmune peripheral neuropathy and that the role of LF is not clear but may be associated with the initial activation of autoreactive T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17226101      PMCID: PMC2771395          DOI: 10.1007/s10719-006-9025-9

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  45 in total

1.  Colorimetric determination of neutral sugars by a resorcinol sulfuric acid micromethod.

Authors:  M Monsigny; C Petit; A C Roche
Journal:  Anal Biochem       Date:  1988-12       Impact factor: 3.365

2.  Isolation of rat liver plasma membrane fragments in isotonic sucrose.

Authors:  N N Aronson; O Touster
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

3.  Quantitative extraction and determination of nonesterified fatty acids in plasma.

Authors:  W G Duncombe; T J Rising
Journal:  J Lipid Res       Date:  1973-03       Impact factor: 5.922

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Synthesis of cerebronic acid from lignoceric acid by rat brain preparation. Some properties and distribution of the -hydroxylation system.

Authors:  M Hoshi; Y Kishimoto
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

6.  Expansion of human gammadelta T cells after in vitro stimulation with Campylobacter jejuni.

Authors:  Ildiko Van Rhijn; Leonard H Van den Berg; C Wim Ang; Joke Admiraal; T Logtenberg
Journal:  Int Immunol       Date:  2003-03       Impact factor: 4.823

Review 7.  The Guillain-Barré syndrome: a true case of molecular mimicry.

Authors:  C Wim Ang; Bart C Jacobs; Jon D Laman
Journal:  Trends Immunol       Date:  2004-02       Impact factor: 16.687

8.  Effects of subperineurial injections of very-long-chain and medium-chain fatty acids into rat sciatic nerve.

Authors:  N C Sacktor; J Griffin; A B Moser; H W Moser
Journal:  Neurochem Pathol       Date:  1986-08

9.  Studies of lipid A fractions from the lipopolysaccharides of Pseudomonas aeruginosa and Pseudomonas alcaligenes.

Authors:  D T Drewry; J A Lomax; G W Gray; S G Wilkinson
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

10.  Full structural characterization of the lipid A components from the Agrobacterium tumefaciens strain C58 lipopolysaccharide fraction.

Authors:  Alba Silipo; Cristina De Castro; Rosa Lanzetta; Antonio Molinaro; Michelangelo Parrilli
Journal:  Glycobiology       Date:  2004-05-24       Impact factor: 4.313

View more
  5 in total

Review 1.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

2.  Gangliosides as a potential new class of stem cell markers: the case of GD1a in human bone marrow mesenchymal stem cells.

Authors:  Sonia Bergante; Enrica Torretta; Pasquale Creo; Nadia Sessarego; Nadia Papini; Marco Piccoli; Chiara Fania; Federica Cirillo; Erika Conforti; Andrea Ghiroldi; Cristina Tringali; Bruno Venerando; Adalberto Ibatici; Cecilia Gelfi; Guido Tettamanti; Luigi Anastasia
Journal:  J Lipid Res       Date:  2014-01-21       Impact factor: 5.922

3.  Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.

Authors:  Robert K Yu; Seigo Usuki; Yutaka Itokazu; Han-Chung Wu
Journal:  Glycobiology       Date:  2015-09-24       Impact factor: 4.313

4.  Topology and patch-clamp analysis of the sodium channel in relationship to the anti-lipid a antibody in campylobacteriosis.

Authors:  Seigo Usuki; Yoshihiko Nakatani; Kyoji Taguchi; Tetsuhiro Fujita; Shinya Tanabe; Iku Ustunomiya; Yihua Gu; Shaun A Cawthraw; Diane G Newell; Mohanasundari Pajaniappan; Stuart A Thompson; Toshio Ariga; Robert K Yu
Journal:  J Neurosci Res       Date:  2008-11-15       Impact factor: 4.164

5.  Novel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: use relevant to Guillain-Barré syndrome.

Authors:  S Usuki; K Taguchi; S A Thompson; P B Chapman; R K Yu
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.